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Abstract
It is thought that the combination of extracellular glutamate
accumulation and mitochondrial damage is involved in neur-
onal death associated with brain ischemia and hypoglycemia,
and some neurodegenerative diseases such as Huntington’s
disease. However, the mechanism whereby those two factors
interact together to trigger neurodegeneration in this and other
neurodegenerative disorders is still elusive. Here, we have
addressed this issue using a model of mild and sustained
accumulation of extracellular glutamate in cerebellar cultured
neurons, which are mostly glutamatergic and commonly used
to study glutamate neurotoxicity. The resulting stimulation of
glutamate receptors triggered a  50% persistent increase in
mitochondrial respiration that was associated with free radi-
cals formation, and which was found to be necessary to pre-
vent the collapse of the mitochondial membrane potential
(Dwm) and apoptotic cell death. In fact, hampering the glu-
tamate-mediated increase in mitochondrial respiration with an
inhibitor of the mitochondrial respiratory chain stopped neu-
rons from producing free radicals, but led them to undergo
rapid and profound Dwm collapse and apoptotic cell death.
Thus, we suggest that the formation of reactive oxygen spe-
cies by glutamate receptor activation is the unavoidable con-
sequence of an increase in the mitochondrial respiration
aimed to prevent Dwm collapse and neurodegeneration. These
results may be relevant to understand the pathophysiology of
those neurodegenerative diseases associated with both mit-
ochondrial respiratory chain and glutamate transporter
defects.
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Glutamate receptor over-stimulation following extracellular
accumulation of the amino acid has been involved in the
pathophysiology associated with brain ischemia, hypogly-
cemia, and certain neurodegenerative disorders, such as
Huntington’s disease (Bittigau and Ikonomidou 1997). It is
well known that glutamate neurotoxicity is exacerbated by
mitochondrial failure, and that even low concentrations not
sufficient to induce neuronal death become neurotoxic in the
presence of mitochondrial toxins. During the ischemic
episode there is a prompt decline in energy levels and a
large increase in the extracellular concentration of glutamate
and aspartate (Benveniste et al. 1984). In addition, prolonged
decreases in mitochondrial activity after brain ischemia have
been described (Anderson and Sims 1999). Diminished
activity of the different components of the mitochondrial
electron transport chain has also been linked to Alzheimer’s,
Parkinson’s and Huntington’s diseases, suggesting that
mitochondrial damage is involved in the pathogenesis of
these disorders. The regulation of the extracellular concen-
trations of glutamate depends on its removal by transporter
proteins. As glutamate transporters are energy and sodium
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dependent carriers that can operate in the reverse direction
during neuronal energy failure, mitochondrial damage would
potentiate the excitotoxic neuronal death during extracellular
glutamate accumulation (Benveniste et al. 1984; Rossi et al.
2000). In fact, in vivo administration of L-trans-pirrolydine
2,4-dicarboxylate (PDC) – an inhibitor of glutamate uptake
seen to increase extracellular concentration of glutamate in
the striatum and the hippocampus – does not cause neuronal
damage in rats (Massieu et al. 1995). Similar results have
been found in cultured cerebellar granule neurons (Cebers
et al. 1999; Garcı´a and Massieu 2001). However, the
administration of PDC to rats previously treated with
subtoxic concentrations of the mitochondrial toxin 3-nitro-
propionic acid (3-NP) or the glycolysis inhibitor, iodoacetate
induces large lesions into those brain areas (Sa´nchez-
Carbente and Massieu 1999; Massieu et al. 2000), in good
agreement with previous in vivo and in vitro studies showing
that metabolic inhibition potentiates glutamate neurotoxicity
(Novelli et al. 1988; Greene and Greenamyre 1995). These
results suggest that, whereas glutamate, at the concentration
reached in the extracellular space during these conditions, or
mitochondrial impairment per se are insufficient factors to
cause neurodegeneration, the combination of both trigger
neuronal death. However, the underlying mechanism respon-
sible for such synergistic effect is yet unknown.
In order to address this issue, we have used a well-
established model of glutamate receptor activation based on
the inhibition of glutamate uptake, which leads to a mild and
sustained increase in the extracellular concentration of
glutamate (Garcı´a and Massieu 2001). We have found
evidence consistent with the notion that glutamate receptor
activation triggers an enhancement in mitochondrial oxygen
consumption focused to prevent the loss of mitochondrial
membrane potential (Dwm), and the apoptotic neuronal death.
We believe that these results may be of relevance to
understand the mechanism of neurotoxicity in certain
pathophysiological conditions, such as ischemia, hypogly-
cemia, or Huntington’s disease, in which, in addition to
mutated Huntingtin, decreased activity of complexes II, III
and IV of the electron transport chain (Gu et al. 1996;
Browne et al. 1997; Panov et al. 2002) and decreased
glutamate transporter (Arzberger et al. 1997) has been
described.
Experimental procedures
Culture of cerebellar neurons
Cerebellar granule neurons in primary culture were obtained from
7–8-day-old Wistar rats as described (Garcı´a and Massieu 2001).
Cells were seeded at 1.5 · 106 cells/well in 6-wells Nunc
(Roskilde, Denmark) plastic Petri dishes previously coated with
poly D-lysine (15 lg/mL) and incubated for 9 days in vitro in
Basal Eagle’s Medium, supplemented with 10% fetal bovine
serum, L-glutamine (2 mM), penicillin (100 U/mL), streptomycin
(100 lg/mL), amphotericin B (0.25 lg/mL), and KCl (25 mM).
Glucose (5 mM) and cytosine arabinoside (10 lM) were added
24 h after plating to inhibit the proliferation of non-neuronal
cells.
Cell treatments
After 9 days in vitro, neurons were incubated in the presence of the
glutamate uptake inhibitor PDC (500 lM) or the succinate dehy-
drogenase inhibitor 3-NP (500 lM), either alone or in combination,
as previously described (Garcı´a and Massieu 2003), for different
time periods (5 min to 4 h). In some experiments, cells were
incubated in the presence of MK-801 (10 lM), superoxide dismutase
(100 U/mL), catalase (100 U/mL) and Nx-nitro-L-arginine mono-
methyl ester (L-NAME, 1 mM), which were added 5 min prior to
PDC addition.
Flow-cytometric analyses of mitochondrial membrane potential
and apoptotic death
Dwm and apoptotic death were determined in the same cellular
suspension by flow cytometry, essentially as previously described
(Almeida et al. 2001; Garcı´a-Nogales et al. 2003). Briefly, cells
were first smoothly scraped off the plates in order to minimize
cellular disruption, and then they were incubated with 5,5¢,6,6¢-
tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazolylcarbocyanine iodide
(JC-1, 3 lM), followed by incubation with APC-conjugated annex-
in-V and 7-amino-actinomycin D (7-AAD) (Becton-Dickinson
Biosciences, Franklin Lakes, NJ, USA). Data acquisition was
performed using a FACScalibur flow cytometer (Becton Dickinson
Biosciences), equipped with a 15 mW argon ion laser tuned at
488 nm, using the CellQuest software (Becton-Dickinson Bio-
sciences). Photomultiplier settings were adjusted to detect JC-1
monomer fluorescence signals on the FL1 detector (green fluores-
cence, centered around 525 nm), and JC-1 aggregate fluorescence
signals on the FL2 detector (red fluorescence, centered around
590 nm). Data analysis was performed using the Paint-A-Gate PRO
software (Becton-Dickinson Biosciences). Mean fluorescence inten-
sity values for FL1 and FL2, expressed as relative linear
fluorescence channels (arbitrary units scaled from channel 0–
10 000) were obtained for all experiments. The relative aggregate/
monomer (red/green) fluorescence intensity values were used for
Dwm data presentation. Preliminary experiments focused to validate
this protocol were performed using the mitochondrial permeability
pore inhibitor, cyclosporin A (10 lM for 15 min), which showed no
effect on FL2/FL1 ratio ( 1.3 a.u., not shown) when compared to
untreated cells. Furthermore, the FL2/FL1 ratio values ( 0.2 a.u.,
not shown) obtained after adding FCCP (5 lM) to the cell
suspensions were similar to those obtained with antimycin A
(10 lg/mL). Annexin V-APC and 7-AAD signals were acquired on
the FL4 and FL3 channels, respectively, to quantitatively determine
the percentage of apoptotic cells. In all cases, the analyzer threshold
was adjusted on the FSC channel to exclude most of the subcellular
debris in order to reduce the background noise due to the cellular
disruption during scrapping. To exclusively quantify cells showing
the early apoptotic feature phosphatidylserine translocation, we
determined those annexin V positive cells that were 7-AAD
negative. As 7-AAD only binds DNA to those cells having a non-
intact plasma membrane (due to both disruption during scrapping
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and necrosis by the treatments), we considered to be apoptotic those
cells that were annexin V+-7-AAD–.
GSH, NADPH and NADH determinations
GSH concentrations were measured by the enzymatic method
described by Tietze (1996) with the modifications described by
Dringen and Hamprecht (1996) (see also Garcı´a-Nogales et al.
2003). NADH and NADPH concentrations were measured in the
cells exactly as described by Garcı´a-Nogales et al. (2003).
Determination of oxygen consumption
Oxygen consumption was determined with a Clark-type electrode
(Rank Brothers, Cambridge, UK) in the intact, resuspended cells at
37C in buffered Hanks’ solution. The rates of oxygen consumption
were calculated from the slopes (monitored for at least 15 min per
trace), and expressed as nmol of oxygen consumed per minute per
0.5 · 106 cells.
Measurement of reactive oxygen species
The formation of intracellular reactive oxygen species (ROS) was
assessed using the dye carboxy-H2DCFDA (20 lM) (Hempel et al.
1999). Its desterification product, carboxy-dichlorofluorescein (carb-
oxy-H2DCF), is cleaved by esterases and remains entrapped within
the cells, hence being prone to ROS-mediated oxidation to
fluorogenic carboxy-DCF (Hempel et al. 1999). To evaluate the
formation of superoxide anion, we used hydroethidine, which is
specifically oxidized by superoxide as previously reported (Bindo-
kas et al. 1996). Thus, after the incubation periods, cells were
washed and further incubated in the presence of hydroethidine
(3.2 lM) for 20 min at 37C. After fixing and mounting the cells in
coverslips, the number of fluorescent neurons was counted in 10
different fields per coverslip from three independent experiments
with the aid an image analyzer (NIH Image 1.6 for Macintosh) and
expressed as percentages.
Determination of complex I activity
For the determination of enzyme activity, cells were washed with
ice-cold phosphate-buffered saline and collected, centrifuged and
resuspended in 300 lL of 0.1 M potassium phosphate buffer
(pH 7.0). Cell suspensions (containing approximately 3–4 mg of
protein/mL) were frozen and thawed three times to ensure cell lysis.
Complex I (NADH–ubiquinone oxidoreductase) activity was meas-
ured by determining the rotenone-sensitive NADH oxidation using
ubiquinone-5 (coenzyme Q1, Sigma, St Louis, MO, USA) as the
electron acceptor (Ragan et al. 1987) in a Hitachi U2000 spectro-
photometer (Hitachi Ltd, Tokio, Japan). Enzyme activity is
expressed as nanomoles per minute per milligram of protein.
Protein determinations
Protein concentrations were determined in cells solubilized with
0.1 M NaOH as Lowry et al. (1951), using bovine serum albumin as
standard.
Statistical analysis
Data are expressed as means ± SEM values. Statistical analysis
was carried out by one-way analysis of variance (ANOVA),
followed by a Fisher’s least significant difference multiple
comparison test.
Results
L-trans-Pirrolydine 2,4-dicarboxylate
and 3-nitropropionic acid depolarize mitochondrial
membrane potential but do not induce neuronal death
In our previous study, we have shown that incubation of
cerebellar neurons with PDC (500 lM) increases extracellu-
lar glutamate concentrations to values ranging from 18 to
35 lM (Garcı´a and Massieu 2001) without inducing neuronal
death at least up to 4 h of incubation (Garcı´a and Massieu
2003). However, in the presence of subtoxic concentrations
of the mitochondrial toxin 3-NP, PDC triggers cell death
(Garcı´a and Massieu 2001, 2003). Now, we have investigated
the mechanisms involved, and we first focused on mitoch-
ondrial membrane potential. Here, we show that inhibition of
glutamate uptake with PDC induced a rapid, but moderate
(by  30%) decrease of Dwm that was sustained for, at least,
the following 4 h of incubation (Fig. 1a). Such a PDC-
dependent loss of Dwm was NMDA receptor-mediated, as it
was fully prevented by MK-801 (JC-1 fluorescence values,
1.21 ± 0.11, 0.80 ± 0.09, 1.11 ± 0.10, arbitrary units, for
Fig. 1 Time course changes in (a) mitochondrial membrane potential
(Dwm) and (b) apoptotic death as measured in cerebellar neurons after
inhibition of glutamate uptake (PDC, 500 lM), inhibition of succinate
dehydrogenase (3-NP, 500 lM) or a combination of both. Dwm and
apoptosis (annexin V+/7-AAD– cells) were measured by flow cytometry
as described in Experimental Procedures. Results are mean ± SEM
values from four to six independent experiments. *p < 0.05 vs. control.
3-NP, 3-nitropropionic acid; PDC, L-trans-pirrolydine 2,4-dicarboxy-
late.
Glutamate increases mitochondrial respiration 185
 2004 International Society for Neurochemistry, J. Neurochem. (2005) 92, 183–190
control, PDC and PDC + MK-801, respectively). On the
other hand, the inhibition of succinate dehydrogenase
activity with 3-NP (500 lM) did not alter Dwm during the
first 30 min of exposure, but induced a large depolarization
after 2 h that declined further at 4 h (Fig. 1a). Co-incubation
of PDC with 3-NP did not result in additional decay of Dwm
as compared with 3-NP alone (Fig. 1a), but enhanced
apoptotic cell death from as soon as 30 min (Fig. 1b). In
contrast, PDC or 3-NP treatments, alone, did not increase the
percentage of apoptotic cells, at least up to 4 h of incubation
(Fig. 1b).
Mitochondrial membrane depolarization induced
by 3-nitropropionic acid is dependent on NADH
concentrations.
As show in Fig. 1(a), treatment with 3-NP led neuronal
Dwm to collapse after 2 h. In view that 3-NP inhibits both
succinate dehydrogenase and complex II of the mitochond-
rial respiratory chain, we next investigated whether
3-NP-induced mitochondrial depolarization was associated
with the loss of reducing equivalents (NADH and
NADPH), which are involved in the maintenance of Dwm.
As shown in Fig. 2(a), NADH concentrations diminished
significantly 2 and 4 h after 3-NP exposure, well correlating
with the observed depolarization of the mitochondrial
membrane (Fig. 1a). In contrast, exposure of neurons to
PDC did not alter NADH concentrations at any of the time
periods studied (Fig. 2a), and the coincubation of 3-NP
with PDC had no additive effect on NADH concentrations
when compared to those induced by 3-NP alone. NADPH
concentrations were not altered by any of these treatments
(Fig. 2b).
Inhibition of glutamate uptake by L-trans-pirrolydine
2,4-dicarboxylate increases oxygen consumption in
cerebellar granule neurons
As shown in Fig. 1(a), PDC produced a brief and rapid Dwm
decrease that was sustained for the following 4 h. In order to
elucidate whether any further Dwm collapse could have been
prevented through the stimulation of the respiratory chain,
the rate of oxygen consumption was monitored after 2 h of
PDC exposure. Control neurons consumed oxygen at a rate
of 0.31 nmol O2 per min per 0.5 · 106 cells (Table 1).
However, incubation of cells with PDC triggered an increase
in the rate of oxygen consumption by 1.4-fold, whereas 3-NP
had no effect (Table 1). To elucidate whether PDC-induced
increase in oxygen consumption was associated to the
activation of NMDA receptors, a group of cells were also
incubated in the presence of the NMDA receptor antagonist,
MK-801. As shown in Table 1, MK-801 prevented the
increase in oxygen consumption induced by PDC. To
ascertain whether such an increase in oxygen consumption
was due to mitochondrial function, 3-NP was added to PDC-
treated respiring cells, and we observed a 95% blockade of
oxygen consumption (not shown). In addition, we have
previously reported that another mitochondrial toxin, sodium
azide, potentiates PDC-mediated cellular death in a similar
experimental paradigm (Garcı´a and Massieu 2001). In view
that an increase in oxidative stress up-regulates complex I
activity, at least in glial cells (Va´squez et al. 2001), we
sought to determine whether such a putative increase would
Fig. 2 Time course changes in (a) NADH and (b) NADPH, as
measured in cerebellar neurons after inhibition of glutamate uptake
(PDC, 500 lM), inhibition of succinate dehydrogenase (3-NP, 500 lM)
or a combination of both. NADH and NADPH concentrations were
measured by chemiluminiscence, as described in Experimental Pro-
cedures. Results are mean ± SEM values from four to six independent
experiments. *p < 0.05 vs. control. 3-NP, 3-nitropropionic acid; PDC,
L-trans-pirrolydine 2,4-dicarboxylate.
Table 1 Inhibition of glutamate uptake with L-trans-pirrolydine
2,4-dicarboxylate (PDC) increases the rate of oxygen consumption in
cerebellar neurons
Rate of oxygen consumption
(nmol O2/min/0.5 · 106 cells)
Control 0.31 ± 0.01
3-NP 0.29 ± 0.02
PDC 0.44 ± 0.04*
PDC + MK-801 0.21 ± 0.07
Oxygen consumption was determined after 2 h exposure of neurons to
PDC (500 lM) or 3-nitropropionic acid (3-NP: 500 lM). MK-801 (10 lM)
was incubated with PDC. Values are mean ± SEM of three inde-
pendent experiments. *p < 0.05 vs. control values; p < 0.05 vs. PDC.
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account for the observed increased respiration rate. However,
treatment of cells with PDC (500 lM, 2 h) resulted in no
change in the activity of complex I (control, 4.4 ± 0.1; PDC,
4.2 ± 0.7 nmol/min/mg of protein; n ¼ 3).
Inhibition of glutamate uptake with L-trans-pirrolydine
2,4-dicarboxylate induces reactive oxygen species
production and decreases GSH concentrations
As an increase in the rate of oxygen consumption would
enhance oxidative metabolism, we sought to investigate
whether PDC treatment led to an increase in ROS production.
Approximately 22% of control neurons showed carboxy-DCF
fluorescence, indicating basal ROS production (Fig. 3a).
However, the presence of PDC significantly increased the
number of fluorescent cells as from 30 min of treatment, and
remained elevated after 2 and 4 h (Fig. 3a). This effect was
inhibited by catalase (100 U/mL) and by MK-801 (10 lM)
(Fig. 3b). In contrast, 3-NP alone did not increase the number
of fluorescent cells at any of the times investigated (Fig. 3a).
Furthermore, the exposure of neurons to PDC plus 3-NP did
not increase the number of fluorescent cells when compared
with PDC alone (Fig. 3a). In order to ascertain whether
superoxide anion was a major ROS component under our
conditions, we next used hydroethidine, i.e. a fluorescent
probe previously shown to specifically detect superoxide
anion in cultured neurons (Bindokas et al. 1996). As shown
in Table 2, 2 h after treatment, neither PDC nor 3-NP alone
were sufficient to generate detectable superoxide, whereas the
combination of PDC with 3-NP significantly increased the
number of fluorescent cells. To investigate whether ROS
production was associated with impairment of GSH status,
GSH concentrations were determined in the same experi-
mental conditions. As shown in Fig. 4(a), PDC treatment
progressively decreased GSH concentrations, reaching the
statistical significance after 2 and 4 h of exposure. In contrast,
3-NP treatment, alone, did not alter GSH concentrations
(Fig. 4a). When 3-NP was combined with PDC, GSH was not
further decreased when compared with PDC treatment alone
(Fig. 4a). The decrease in GSH concentrations observed 2 h
after PDC treatment was not prevented by superoxide
dismutase (100 U/mL) or L-NAME (1 mM) (results not
shown). However, it was partially prevented by catalase
(100 U/mL) and MK-801 (10 lM) (Fig. 4b).
Discussion
Glutamate uptake inhibition with PDC induced a rapid and
modest Dwm fall that was sustained further, whereas the
inhibition of mitochondrial respiratory chain with 3-NP
largely depolarized mitochondria in a delayed (2 h) manner.
In contrast to 3-NP, PDC-mediated loss of Dwm was not
related to the loss of reducing equivalents and therefore to the
impairment of mitochondrial electron flow, but rather to
calcium influx into the mitochondria after activation of
NMDA receptors. This result is in good agreement with the
well-known role of calcium influx to the mitochondria in the
Dwm loss and excitotoxicity (Schinder et al. 1996; White and
Reynolds 1996; Peng and Greenamyre 1998; Fiskum et al.
Fig. 3 Inhibition of glutamate uptake by PDC induces ROS production
in cultured cerebellar granule cells. (a) ROS production were deter-
mined after exposure of cells to PDC (500 lM) or 3-NP (500 lM), either
alone or in combination. (b) ROS production were also measured at
2 h after PDC (500 lM) treatment, either in the absence or in the
presence of catalase (100 U/mL) or MK-801 (10 lM). ROS production
was assessed by determination of oxidation products of carboxy-DCF.
Data are mean ± SEM values from three (carboxy-DCF) independent
experiments. *p < 0.05 vs. control; #p < 0.05 vs. PDC. CAT, catalase;
DCF, dichlorofluoroscein; 3-NP, 3-nitropropionic acid; PDC, L-trans-
pirrolydine 2,4-dicarboxylate; ROS, reactive oxygen species.
Table 2 Effect of L-trans-pirrolydine 2,4-dicarboxylate (PDC) and
3-nitropropionic acid (3-NP) on superoxide anion production by cere-
bellar neurons, as assessed by hydroethidine fluorescence
Hydroethidine fluorescence
(% of positive cells per field)
Control 2.3 ± 0.9
PDC 5.2 ± 1.2
3-NP 5.6 ± 0.3
PDC + 3-NP 10.3 ± 1.5*
Cells were treated with PDC (500 lM), 3-NP (500 lM) or a combination
of both for 2 h, washed and further incubated in the presence of
hydroethidine. After washing and fixing, cells were mounted and
analyzed by fluorescence microscopy. Each value represent the
mean ± SEM values from four to six different cell culture preparations.
*p < 0.05 vs. control values.
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1999; Duchen 2000; Nicholls et al. 2003). However, none of
these treatments affected cell survival, at least during the 4 h
investigated. Interestingly, apoptotic cell death was triggered
only when both PDC and 3-NP were simultaneously present,
despite no further decline in Dwm was observed when
compared to 3-NP treatment alone. Such a Dwm loss would
hence be associated with the widely held notion that
excitotoxicity occurs through mitochondrial dysfunction
leading to ATP depletion (Ankarcrona et al. 1995; Pang
and Geddes 1997; Almeida and Bolan˜os 2001; Garcı´a and
Massieu 2003).
Interestingly, the dual inhibition of succinate dehydroge-
nase and complex II of the mitochondrial respiratory chain
occurring in the cerebellar neurons exposed to 3-NP (Garcı´a
and Massieu 2001) was insufficient to trigger immediate
Dwm loss. Such Dwm loss occurred only after 2 h of 3-NP
treatment, and was well correlated with NADH, but not
NADPH depletion, strongly suggesting that, during this time,
Dwm would be maintained at the expense of complex
I-mediated NADH oxidation. Only when endogenous NADH
content is exhausted, due to the inhibition of succinate
dehydrogenase activity, the subsequent complex I dysfunc-
tion will fail to properly maintain Dwm. In any case, Dwm loss
induced under this condition does not appear to compromise
neuronal survival, suggesting that mitochondrial depolariza-
tion, per se, would be insufficient to cause neuronal death.
Non-toxic glutamate receptor activation during PDC
exposure partially decreased but did not disrupt completely
Dwm. To understand the mechanism whereby Dwm was not
collapsed and cells survived to such mild glutamate receptor
activation, we next investigated the rate of mitochondrial
oxygen consumption. Cells responded to PDC treatment by
increasing the rate of mitochondrial oxygen consumption.
Such an increase in oxygen consumption would be associ-
ated with Dwm maintenance, because Dwm in PDC-treated
cells was lost only when mitochondrial respiratory chain was
inhibited. Furthermore, the stimulation of mitochondrial
respiration was accompanied by enhanced ROS production
and GSH depletion, in good agreement with previous studies
reporting that superoxide anion would be formed during
glutamate excitotoxicity (Lafo´n-Cazal et al. 1993; Dugan
et al. 1995). However, no detectable superoxide was
observed after 2 h with PDC alone, whereas it did increase
ROS production, suggesting that superoxide may be rapidly
transformed into hydrogen peroxide. In fact, catalase, but not
superoxide dismutase, prevented PDC-mediated dichloroflu-
orescein fluorescence and GSH depletion. Moreover, the
decrease in GSH might be associated with the recently
described impaired GSH biosynthesis – a consequence of the
lack of the GSH precursor, glutamate – in a similar model of
excitotoxicity (Chen and Swanson 2003; Himi et al. 2003;
Re´ et al. 2003). However, this is not the case under our
circumstances, because both GSH depletion and ROS
production induced by PDC were prevented by MK-801.
These results strongly suggest that ROS production and GSH
depletion are the consequence of NMDA receptors activation
by the glutamate accumulated in the extracellular medium.
In conclusion, our results suggest that the accumulation of
endogenous extracellular glutamate after inhibition of its
transporters induces a partial Dwm loss that is compensated
by the stimulation of mitochondrial respiratory chain activity,
which leads to ROS production and GSH deficiency in a
manner dependent on NMDA receptor activation. Such a
compensative mechanism appears to support neuronal survi-
val, unless there is concomitant mitochondrial respiratory
chain deficiency hampering such a neuroprotective strategy.
Prolonged inhibition of mitochondrial respiratory chain
activity has been observed after cerebral ischemia (Anderson
and Sims 1999) and in postmortem brain tissue samples
obtained from Huntington’s disease subjects (Gu et al. 1996;
Browne et al. 1997). Moreover, the excitotoxicity associated
with these pathologies has been suggested to be a conse-
quence of decreased glutamate transport (Arzberger et al.
1997; Mitani and Tanaka 2003). These observations suggest
that in addition to the expansion of the CAG codon in
Fig. 4 Inhibition of glutamate uptake by PDC depletes GSH in cul-
tured cerebellar granule cells. (a) GSH concentrations were deter-
mined after exposure of cells to PDC (500 lM) or 3-NP (500 lM), either
alone or in combination. (b) GSH concentrations were also measured
at 2 h after PDC (500 lM) treatment, either in the absence or in the
presence of catalase (100 U/mL) or MK-801 (10 lM). GSH concen-
trations were determined enzymatically as described in Material and
Methods. Data are mean ± SEM values from six (GSH) independent
experiments. *p < 0.05 vs. control; #p < 0.05 vs. PDC. CAT, catalase;
3-NP, 3-nitropropionic acid; PDC, L-trans-pirrolydine 2,4-dicarboxy-
late.
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Huntingtin protein associated with Huntington’s disease
patients, an excitotoxic mechanism, probably precipitated
by a progressive decline in mitochondrial function, might be
involved in the pathogenesis of this disease (Zeron et al.
2001; Panov et al. 2002). Thus, our results may contribute to
understanding the mechanisms involved in neuronal death
associated with cerebral ischemia and certain neurodegener-
ative disorders, such as Huntington’s disease.
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